Sponsored Research
Christopher Granger of Cardiology has received a sub-award () through the Harvard Pilgrim Health Care, Inc. for a project entitled "Shingrix." Total funding will be $117,500.
Senthil Selvaraj of Cardiology has received an award from the American Heart Association for a project entitled "Dissecting the Ketone Metabolic Axis in Heart Failure with Reduced Ejection Fraction." Total funding will be $230,934.
Emily J. Alway (Mentor: Diego Bohorquez) of Gastroenterology has received an award (1F30-DK136229-01) from the National Institutes of Health for a project entitled "Rapid sugar sensing from gut to brain." Total funding will be $145,182.
Ranee Chatterjee Montgomery of General Internal Medicine has received a sub-award (5U-19AG065188-02) through the DCRI-Duke-Site for a project entitled "Pragmatic Evaluation of Events and Benefits of Lipid-lowering in Older Adults (PREVENTABLE)." Total funding to be determined.
Christopher Bowling of Geriatrics has received a sub-award (1R01-HL165452-01) through the Weill Cornell Medicine for a project entitled "REGARDS-MI-4." Total funding will be $350,734.
Andrew Alspaugh of Infectious Diseases has received an award (1R01-AI175711-01) from the National Institutes of Health for a project entitled "Coordinated responses to host-derived stresses in C. neoformans." Total funding will be $1,874,068.
Thuy Le of Infectious Diseases has received an award from the CDC Foundation for a project entitled "REPRODUCIBILITY AND CLINICAL SIGNIFICANCE OF THE CRAG SQ SCORES IN A COHORT ASYMPTOMATIC CRAG POSITIVE PATIENTS WITH ADVANCED HIV DISEASE IN VIETNAM - IIS." Total funding will be $21,933.
Nathan Thielman of Infectious Diseases has received a sub-award (1R21-TW011667-01A1) through the University of South Carolina for a project entitled "Confidential Social Network Referrals for HIV Testing." Total funding will be $113,171.
Nicholas Turner of Infectious Diseases has received a sub-award (5U54-CK000609-02-00-) through the Washington University in St. Louis for a project entitled "Clinical, Metagenomic, and Metabolomic Predictors of Infections and Asymptomatic Colonization due to Community-Associated ESBL-producing Enterbacterales (PREDICT CA-ESBL Aim 1)." Total funding will be $57,190.
David Murdoch of Pulmonary has received a sub-award (4UH3-HL154944-02) through the Weill Cornell Medicine for a project entitled "1/2 Doxycycline for Emphysema in People Living with HIV: The DEPTH Trial." Total funding to be determined.
Laurie Snyder of Pulmonary has received an award from the Cystic Fibrosis Foundation for a project entitled "Cystic Fibrosis Lung Transplant Consortium." Total funding will be $167,651.
Aparna Swaminathan of Pulmonary has received an award (1K23-HL163381-01A1) from the National Institutes of Health for a project entitled "Complement Pathway Activation in Idiopathic Pulmonary Fibrosis and other Progressive Fibrosing Interstitial Lung Diseases (K23)." Total funding will be $943,430.
Lisa Criscione-Schreiber of Rheumatology has received an award from the Rheumatology Research Foundation for a project entitled "RRF - Amgen Fellowship Training Award." Total funding will be $50,000.
Ankoor Shah of Rheumatology has received a sub-award (3U19-AI110483-08S4) through the Emory University for a project entitled "ACV01P - Cost Reimbursable." Total funding to be determined.
Industry Sponsored Clinical Trials
Gary Felker of Cardiology has received an award from Cytokinetics, Inc. for a project entitled "Design Studio." Total funding will be $58,395.
Marat Fudim of Cardiology has received an award from Reprieve Cardiovascular, Inc. for a project entitled "Fluid management of Acute decompensated heart failure subjects treated with reprieve decongestion management system (DMS) - FASTR Trial." Total funding will be $254,126.
Adrian Hernandez of Cardiology has received an award from Otsuka Pharmaceutical Development & Commercialization, Inc. for a project entitled "Design Studio." Total funding will be $50,000.
Jennifer Rymer of Cardiology has received an award from Abiomed for a project entitled "Patient Advisory Board and Faculty Effort across multiple studies." Total funding will be $252,754.
Harry Erba of Cell Therapy has received an award from Aptose Biosciences Inc. for a project entitled "HM-FLTI-101." Total funding will be $1,289,825.
Harry Erba of Cell Therapy has received an award from MacroGenics, Inc. for a project entitled "MacroGenics MGD024-01: A Phase 1, First-in-Human, Dose Escalation Study of MGD024, a CD123 x CD3 Bispecific DART Molecule, in Patients with Select Relapsed or Refractory Hematologic Malignancies." Total funding will be $1,036,935.
David Leiman of Gastroenterology has received an award from Celgene International II Sarl for a project entitled "A PHASE 3, MULTI-CENTER, MULTI-NATIONAL, OPEN-LABEL EXTENSION STUDY TO EVALUATE THE LONG-TERM SAFETY OF CC-93538 IN ADULT AND ADOLESCENT SUBJECTS WITH EOSINOPHILIC ESOPHAGITIS." Total funding will be $60,124.
Kathryn Starr of Geriatrics has received an award from Eggland's Best, LLC for a project entitled "Effect of Nutrient Rich Egg Intervention on Vision, Function and Cognition in Older Adults with Early Age-Related Macular Degeneration." Total funding will be $294,892.
Thomas Ortel of Hematology has received an award from Takeda Development Center Americas, Inc for a project entitled "TAK-755-2001 A Phase 2b, multicenter, randomized, double-blind study of safety and efficacy of TAK-755 (rADAMTS13) with minimal to no plasma exchange (PEX) in the treatment of immune-mediated thrombotic thrombocytopenic purpura (iTTP)." Total funding will be $165,757.
Daniel George of Oncology has received an award from Surface Oncology for a project entitled "Surf-617: SRF617 + Etrumadenant + Zimberelimab for mCRPC." Total funding will be $26,860.
Christopher Hoimes of Oncology has received an award from Synthekine for a project entitled "Synthekine STK-012." Total funding will be $726,110.
Gretchen Kimmick of Oncology has received an award from Dana-Farber Cancer Institute for a project entitled "A randomized phase II trial of adjuvant trastuzumab emtansine (T-DM1) followed by subcutaneous trastuzumab versus paclitaxel in combination with subcutaneous trastuzumab for Stage I HER2-positive breast cancer (ATEMPT 2.0)." Total funding will be $100,069.
John Strickler of Oncology has received an award from Erasca, Inc for a project entitled "ERAS-007 ERK Inhibitor for Advanced or Metastatic Solid Tumors." Total funding will be $15,960.
Hope Uronis of Oncology has received an award from Arcus Biosciences for a project entitled "A Randomized, Open-Label, Multicenter Phase 3 Trial of Domvanalimab, Zimberelimab, and Chemotherapy Versus Nivolumab and Chemotherapy in Participants with Previously Untreated Locally Advanced Unresectable or Metastatic Gastric, Gastroesophageal Junc." Total funding will be $1,449,273.
Hope Uronis of Oncology has received an award from Adaptimmune Limited for a project entitled "ADP-0055." Total funding will be $23,623.
William St Clair of Rheumatology has received a sub-award (5UM1-AI109565-09) through Horizon Therapeutics Ireland DAC for a project entitled "Combining a CD40L-Binding Protein (VIB4920) with a TNF- Inhibitor for the Treatment of Inadequately Controlled Rheumatoid Arthritis 9ITN CONTROL-RA Trial." Total funding to be determined.